Clinical Trial Update: Application of Somatostatin for Advanced Gastric Cancer After D2 Lymph Node Dissection [Phase 4]

View source ↗

Summary

A completed Phase 4 clinical trial evaluating somatostatin for advanced gastric cancer after D2 lymph node dissection.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• Somatostatin (somatostatin)

Snippet

Sponsor: First Affiliated Hospital, Sun Yat-Sen University | Conditions: Gastric Cancer After D2 Lymph Node Dissection | Phase 4 | Status: COMPLETED